Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Cash from Financing Activities (2023 - 2025)

Vsee Health (VSEE) has disclosed Cash from Financing Activities for 3 consecutive years, with $943012.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 34.85% year-over-year to $943012.0, compared with a TTM value of $2.7 million through Sep 2025, down 47.86%, and an annual FY2024 reading of $6.0 million, up 1047.25% over the prior year.
  • Cash from Financing Activities was $943012.0 for Q3 2025 at Vsee Health, up from $209667.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $3.6 million in Q2 2024 and bottomed at $70000.0 in Q2 2023.
  • Average Cash from Financing Activities over 3 years is $823711.9, with a median of $393186.5 recorded in 2023.
  • The sharpest move saw Cash from Financing Activities skyrocketed 5039.77% in 2024, then crashed 94.17% in 2025.
  • Year by year, Cash from Financing Activities stood at $70000.0 in 2023, then surged by 1296.9% to $977832.0 in 2024, then decreased by 3.56% to $943012.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for VSEE at $943012.0 in Q3 2025, $209667.0 in Q2 2025, and $536373.0 in Q1 2025.